Beaumont Financial Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-14,163
| Closed | -$1.41M | – | 304 |
|
|
2019
Q3 | $1.41M | Sell |
14,163
-380
| -3% | -$36.1K | 0.14% | 105 |
|
|
2019
Q2 | $1.34M | Sell |
14,543
-48
| -0.3% | -$4.56K | 0.14% | 103 |
|
|
2019
Q1 | $1.38M | Buy |
14,591
+30
| +0.2% | +$2.62K | 0.15% | 96 |
|
|
2018
Q4 | $933K | Sell |
14,561
-970
| -6% | -$71.6K | 0.15% | 86 |
|
|
2018
Q3 | $1.39M | Hold |
15,531
| – | – | 0.14% | 84 |
|
|
2018
Q2 | $1.23M | Sell |
15,531
-34
| -0.2% | -$2.82K | 0.13% | 86 |
|
|
2018
Q1 | $1.39M | Buy |
15,565
+4,234
| +37% | +$406K | 0.15% | 87 |
|
|
2017
Q4 | $1.18M | Sell |
11,331
-694
| -6% | -$78.3K | 0.14% | 94 |
|
|
2017
Q3 | $1.75M | Buy |
12,025
+162
| +1% | +$22.1K | 0.22% | 83 |
|
|
2017
Q2 | $1.54M | Sell |
11,863
-667
| -5% | -$81.7K | 0.2% | 84 |
|
|
2017
Q1 | $1.56M | Buy |
12,530
+840
| +7% | +$101K | 0.21% | 84 |
|
|
2016
Q4 | $1.35M | Buy |
11,690
+94
| +0.8% | +$10.5K | 0.2% | 82 |
|
|
2016
Q3 | $1.21M | Hold |
11,596
| – | – | 0.19% | 87 |
|
|
2016
Q2 | $1.14M | Sell |
11,596
-396
| -3% | -$41K | 0.19% | 82 |
|
|
2016
Q1 | $1.38M | Buy |
11,992
+396
| +3% | +$40.8K | 0.22% | 77 |
|
|
2015
Q4 | $1.39M | Hold |
11,596
| – | – | 0.23% | 68 |
|
|
2015
Q3 | $1.34M | Hold |
11,596
| – | – | 0.19% | 79 |
|
|
2015
Q2 | $1.34M | Sell |
11,596
-396
| -3% | -$45.3K | 0.19% | 79 |
|
|
2015
Q1 | $1.38M | Hold |
11,992
| – | – | 0.05% | 93 |
|
|
2014
Q4 | $1.34M | Hold |
11,992
| – | – | 0.06% | 93 |
|
|
2014
Q3 | $1.14M | Hold |
11,992
| – | – | 0.07% | 98 |
|
|
2014
Q2 | $1.03M | Sell |
11,992
-110
| -0.9% | -$8.37K | 0.07% | 105 |
|
|
2014
Q1 | $845K | Sell |
12,102
-502
| -4% | -$39.8K | 0.07% | 92 |
|
|
2013
Q4 | $1.06M | Buy |
12,604
+1,122
| +10% | +$88.8K | 0.09% | 91 |
|
|
2013
Q3 | $885K | Sell |
11,482
-28
| -0.2% | -$1.96K | 0.08% | 92 |
|
|
2013
Q2 | $673K | Buy |
+11,510
| New | +$693K | 0.06% | 102 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Beaumont Financial Advisors's CELG Position: Q4 2019 in Review
Beaumont Financial Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 14,163 shares — an estimated $1.41M sold.
Beaumont Financial Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.75M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Beaumont Financial Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Beaumont Financial Advisors sold 14,163 Celgene Corp shares in Q4 2019, an estimated $1.41M.
- Beaumont Financial Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Beaumont Financial Advisors's Celgene Corp position peaked at $1.75M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Beaumont Financial Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.